British Journal of Pharmacology http://www.nature.com/bjp/current_issue/ Nature Publishing Group en Copyright © Nature Publishing Group British Journal of Pharmacology 0007-1188 Copyright © Nature Publishing Group permissions@nature.com British Journal of Pharmacology http://www.nature.com/aj/images/logos_b_o_w/bjp.gif http://www.nature.com/bjp/ Brivaracetam: a rational drug discovery success story http://dx.doi.org/10.1038/bjp.2008.221 Brivaracetam: a rational drug discovery success story

British Journal of Pharmacology 154, 1555 (August 2008). doi:10.1038/bjp.2008.221

Author: M A Rogawski

]]> Brivaracetam: a rational drug discovery success story M A Rogawski doi:10.1038/bjp.2008.221 British Journal of Pharmacology 154, 1555 (August 2008) June 16, 2008 British Journal of Pharmacology June 16, 2008 154 8 1555 1557 Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans http://dx.doi.org/10.1038/bjp.2008.185 Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

British Journal of Pharmacology 154, 1558 (August 2008). doi:10.1038/bjp.2008.185

Authors: I Wessler & C J Kirkpatrick

]]> Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans I Wessler C J Kirkpatrick doi:10.1038/bjp.2008.185 British Journal of Pharmacology 154, 1558 (August 2008) May 26, 2008 British Journal of Pharmacology May 26, 2008 154 8 1558 1571 Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders http://dx.doi.org/10.1038/bjp.2008.204 Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders

British Journal of Pharmacology 154, 1572 (August 2008). doi:10.1038/bjp.2008.204

Authors: B M Jensen, C Akin & A M Gilfillan

]]> Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders B M Jensen C Akin A M Gilfillan doi:10.1038/bjp.2008.204 British Journal of Pharmacology 154, 1572 (August 2008) May 26, 2008 British Journal of Pharmacology May 26, 2008 154 8 1572 1582 Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK http://dx.doi.org/10.1038/bjp.2008.207 Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK

British Journal of Pharmacology 154, 1583 (August 2008). doi:10.1038/bjp.2008.207

Author: A R Green

]]> Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK A R Green doi:10.1038/bjp.2008.207 British Journal of Pharmacology 154, 1583 (August 2008) May 26, 2008 British Journal of Pharmacology May 26, 2008 154 8 1583 1599 Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats http://dx.doi.org/10.1038/bjp.2008.205 Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats

British Journal of Pharmacology 154, 1600 (August 2008). doi:10.1038/bjp.2008.205

Authors: L Jolly, J E March, P A Kemp, T Bennett & S M Gardiner

]]> Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats L Jolly J E March P A Kemp T Bennett S M Gardiner doi:10.1038/bjp.2008.205 British Journal of Pharmacology 154, 1600 (August 2008) May 26, 2008 British Journal of Pharmacology May 26, 2008 154 8 1600 1610 Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use http://dx.doi.org/10.1038/bjp.2008.208 Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use

British Journal of Pharmacology 154, 1611 (August 2008). doi:10.1038/bjp.2008.208

Authors: G D'Agostino, A M Condino, L Gioglio, F Zonta, M Tonini & A Barbieri

]]> Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use G D'Agostino A M Condino L Gioglio F Zonta M Tonini A Barbieri doi:10.1038/bjp.2008.208 British Journal of Pharmacology 154, 1611 (August 2008) June 2, 2008 British Journal of Pharmacology June 2, 2008 154 8 1611 1618 Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation http://dx.doi.org/10.1038/bjp.2008.209 Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation

British Journal of Pharmacology 154, 1619 (August 2008). doi:10.1038/bjp.2008.209

Authors: T Christ, E Wettwer, N Voigt, O Hála, S Radicke, K Matschke, A Várro, D Dobrev & U Ravens

]]> Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation T Christ E Wettwer N Voigt O Hála S Radicke K Matschke A Várro D Dobrev U Ravens doi:10.1038/bjp.2008.209 British Journal of Pharmacology 154, 1619 (August 2008) June 9, 2008 British Journal of Pharmacology June 9, 2008 154 8 1619 1630 Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype http://dx.doi.org/10.1038/bjp.2008.214 Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype

British Journal of Pharmacology 154, 1631 (August 2008). doi:10.1038/bjp.2008.214

Authors: N Foudi, L Kotelevets, L Louedec, G Leséche, D Henin, E Chastre & X Norel

]]> Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype N Foudi L Kotelevets L Louedec G Leséche D Henin E Chastre X Norel doi:10.1038/bjp.2008.214 British Journal of Pharmacology 154, 1631 (August 2008) June 2, 2008 British Journal of Pharmacology June 2, 2008 154 8 1631 1639 Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors http://dx.doi.org/10.1038/bjp.2008.218 Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors

British Journal of Pharmacology 154, 1640 (August 2008). doi:10.1038/bjp.2008.218

Authors: M Mączewski, J Mączewska & M Duda

]]> Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors M Mączewski J Mączewska M Duda doi:10.1038/bjp.2008.218 British Journal of Pharmacology 154, 1640 (August 2008) June 9, 2008 British Journal of Pharmacology June 9, 2008 154 8 1640 1648 CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats http://dx.doi.org/10.1038/bjp.2008.219 CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats

British Journal of Pharmacology 154, 1649 (August 2008). doi:10.1038/bjp.2008.219

Authors: K D Vandegriff, M A Young, J Lohman, A Bellelli, M Samaja, A Malavalli & R M Winslow

]]> CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats K D Vandegriff M A Young J Lohman A Bellelli M Samaja A Malavalli R M Winslow doi:10.1038/bjp.2008.219 British Journal of Pharmacology 154, 1649 (August 2008) June 9, 2008 British Journal of Pharmacology June 9, 2008 154 8 1649 1661 Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A http://dx.doi.org/10.1038/bjp.2008.198 Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

British Journal of Pharmacology 154, 1662 (August 2008). doi:10.1038/bjp.2008.198

Authors: A Matagne, D-G Margineanu, B Kenda, P Michel & H Klitgaard

]]> Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A A Matagne D-G Margineanu B Kenda P Michel H Klitgaard doi:10.1038/bjp.2008.198 British Journal of Pharmacology 154, 1662 (August 2008) May 26, 2008 British Journal of Pharmacology May 26, 2008 154 8 1662 1671 Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 http://dx.doi.org/10.1038/bjp.2008.211 Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5

British Journal of Pharmacology 154, 1672 (August 2008). doi:10.1038/bjp.2008.211

Authors: D De Filippis, A Russo, A D'Amico, G Esposito, P Concetta, M Cinelli, G Russo & T Iuvone

]]> Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 D De Filippis A Russo A D'Amico G Esposito P Concetta M Cinelli G Russo T Iuvone doi:10.1038/bjp.2008.211 British Journal of Pharmacology 154, 1672 (August 2008) June 16, 2008 British Journal of Pharmacology June 16, 2008 154 8 1672 1679 Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein http://dx.doi.org/10.1038/bjp.2008.213 Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein

British Journal of Pharmacology 154, 1680 (August 2008). doi:10.1038/bjp.2008.213

Authors: J Gierten, E Ficker, R Bloehs, K Schlömer, S Kathöfer, E Scholz, E Zitron, C Kiesecker, A Bauer, R Becker, H A Katus, C A Karle & D Thomas

]]> Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein J Gierten E Ficker R Bloehs K Schlömer S Kathöfer E Scholz E Zitron C Kiesecker A Bauer R Becker H A Katus C A Karle D Thomas doi:10.1038/bjp.2008.213 British Journal of Pharmacology 154, 1680 (August 2008) June 2, 2008 British Journal of Pharmacology June 2, 2008 154 8 1680 1690 Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects http://dx.doi.org/10.1038/bjp.2008.210 Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects

British Journal of Pharmacology 154, 1691 (August 2008). doi:10.1038/bjp.2008.210

Authors: M I Mohammed Abdul, X Jiang, K M Williams, R O Day, B D Roufogalis, W S Liauw, H Xu & A J McLachlan

]]> Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects M I Mohammed Abdul X Jiang K M Williams R O Day B D Roufogalis W S Liauw H Xu A J McLachlan doi:10.1038/bjp.2008.210 British Journal of Pharmacology 154, 1691 (August 2008) June 2, 2008 British Journal of Pharmacology June 2, 2008 154 8 1691 1700 Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 http://dx.doi.org/10.1038/bjp.2008.314 Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5

British Journal of Pharmacology 154, 1701 (August 2008). doi:10.1038/bjp.2008.314

Authors: D De Filippis, A Russo, A D'Amico, G Esposito, C Pietropaolo, M Cinelli, G Russo & T Iuvone

]]> Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 D De Filippis A Russo A D'Amico G Esposito C Pietropaolo M Cinelli G Russo T Iuvone doi:10.1038/bjp.2008.314 British Journal of Pharmacology 154, 1701 (August 2008) British Journal of Pharmacology 154 8 1701 1701 Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice http://dx.doi.org/10.1038/bjp.2008.282 Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice

British Journal of Pharmacology 154, 1702 (August 2008). doi:10.1038/bjp.2008.282

Authors: Y-H Wang, Y-C Shen, J-F Liao, C-H Lee, C-Y Chou, K-T Liou & Y-C Chou

]]> Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice Y-H Wang Y-C Shen J-F Liao C-H Lee C-Y Chou K-T Liou Y-C Chou doi:10.1038/bjp.2008.282 British Journal of Pharmacology 154, 1702 (August 2008) British Journal of Pharmacology 154 8 1702 1702